Bildkälla: Stockfoto

Medivir: Impressive TTP of 10.8 months - Redeye

Redeye comments on Medivir’s update from ESMO GI, showing improvements in fostrox’ TTP.

Redeye comments on Medivir’s update from ESMO GI, showing improvements in fostrox’ TTP.
Börsvärldens nyhetsbrev
ANNONSER